TY - JOUR
KW - Buprenorphine/therapeutic use
KW - Cross-Sectional Studies
KW - Health Occupations
KW - Humans
KW - Opiate Substitution Treatment
KW - Opioid-Related Disorders/drug therapy
KW - Oregon
KW - Students, Health Occupations
KW - undergraduate medical education
KW - Addiction
KW - buprenorphine
KW - opioid use disorder
KW - substance use disorders
KW - waiver training
AU - J. L. Robbins
AU - K. Bonuck
AU - P. Thuillier
AU - C. Buist
AU - P. A. Carney
A1 - 
AB - Background: Addressing the opioid crisis requires an understanding of how to train both health professional students and practicing clinicians on medications for opioid use disorder (mOUD). We designed a robust evaluation instrument to assess the impact of training on perceived clinical knowledge in these different categories of learners. Methods: We enrolled 3rd and 4th year medical, physician assistant (PA), and nurse practitioner (NP) students, as well as practicing PAs, NPs, and physicians to undertake the Drug Addiction Treatment Act (DATA) Waiver Training for mOUD. We designed and implemented a cross-sectional survey to assess perceived change in clinical knowledge as a result of training in opioid use disorder and satisfaction with training. Results: Twenty-one MD/DO and 45 NP/PA students, and 24 practicing MD/DO and 27 NP/PAs completed the survey. Among health professional students (n = 66) and practicing clinicians (n =51), perceived clinical knowledge scores increased significantly (p < 0.001) for all 13 variables. Program evaluation scores for the buprenorphine waiver training were high with no statistical differences between students and practicing clinicians. Overall, the majority of participants indicated they would recommend the training to a colleague (Students' score = 4.84; practicing clinician scores = 4.53; scale = strongly disagree = 1 to strongly agree = 5). Conclusions: Our novel instrument allowed us to determine that the implementation of buprenorphine waiver trainings for health professional students and practicing clinicians leads to significant increases in perceived knowledge, interest and confidence in diagnosing and treating OUD. Although the buprenorphine waiver can now be obtained without training, many waivered providers still do not prescribe buprenorphine; integrating training into medical, NP, and PA curriculum for students and offering the training to practicing clinicians may increase confidence and uptake of mOUD.
AD - Internal Medicine, Division of General Internal Medicine & Geriatrics, Section of Addiction Medicine, School of Medicine, Oregon Health & Science University, Portland, OR, USA.; Department of Family Medicine, School of Medicine, Oregon Health & Science University, Portland, OR, USA.; Department of Dermatology, School of Medicine, Knight Cancer Institute, Portland, OR, USA.; Department of Anesthesiology and Perioperative Medicine & Psychiatry, School of Medicine, Oregon Health & Science University, Portland, OR, USA.; Department of Family Medicine, School of Medicine, Oregon Health & Science University, Portland, OR, USA.
BT - Substance abuse
C5 - Education & Workforce; Measures; Opioids & Substance Use
CP - 1
CY - United States
DO - 10.1080/08897077.2021.2010260
IS - 1
JF - Substance abuse
LA - eng
M1 - Journal Article
N2 - Background: Addressing the opioid crisis requires an understanding of how to train both health professional students and practicing clinicians on medications for opioid use disorder (mOUD). We designed a robust evaluation instrument to assess the impact of training on perceived clinical knowledge in these different categories of learners. Methods: We enrolled 3rd and 4th year medical, physician assistant (PA), and nurse practitioner (NP) students, as well as practicing PAs, NPs, and physicians to undertake the Drug Addiction Treatment Act (DATA) Waiver Training for mOUD. We designed and implemented a cross-sectional survey to assess perceived change in clinical knowledge as a result of training in opioid use disorder and satisfaction with training. Results: Twenty-one MD/DO and 45 NP/PA students, and 24 practicing MD/DO and 27 NP/PAs completed the survey. Among health professional students (n = 66) and practicing clinicians (n =51), perceived clinical knowledge scores increased significantly (p < 0.001) for all 13 variables. Program evaluation scores for the buprenorphine waiver training were high with no statistical differences between students and practicing clinicians. Overall, the majority of participants indicated they would recommend the training to a colleague (Students' score = 4.84; practicing clinician scores = 4.53; scale = strongly disagree = 1 to strongly agree = 5). Conclusions: Our novel instrument allowed us to determine that the implementation of buprenorphine waiver trainings for health professional students and practicing clinicians leads to significant increases in perceived knowledge, interest and confidence in diagnosing and treating OUD. Although the buprenorphine waiver can now be obtained without training, many waivered providers still do not prescribe buprenorphine; integrating training into medical, NP, and PA curriculum for students and offering the training to practicing clinicians may increase confidence and uptake of mOUD.
PP - United States
PY - 2022
SN - 1547-0164; 0889-7077
SP - 825
EP - 833
EP - 
T1 - Differences in perceived clinical knowledge uptake among health profession students and licensed clinicians receiving buprenorphine waiver training in Oregon
T2 - Substance abuse
TI - Differences in perceived clinical knowledge uptake among health profession students and licensed clinicians receiving buprenorphine waiver training in Oregon
U1 - Education & Workforce; Measures; Opioids & Substance Use
U2 - 35130133
U3 - 10.1080/08897077.2021.2010260
VL - 43
VO - 1547-0164; 0889-7077
Y1 - 2022
ER -